Markus Vogtle - Novartis | 人才画像

基本信息

Career Trajectory

Bio

Markus Vogtle currently works at the Global Discovery Chemistry, Novartis. Markus does research in Medicinal Chemistry, Catalysis and Organic Chemistry. Their most recent publication is 'Discovery of amino-1,4-oxazines as potent BACE-1 inhibitors'.

Research Interests

Papers共 27 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Discovery and in Vivo Exploration of 1,3,4-Oxadiazole and Α-Fluoroacrylate Containing IL-17 Inhibitors

Juraj Velcicky,Matthias R. Bauer,Achim Schlapbach,Guillaume Lapointe,Arndt Meyer,Markus Vogtle,Ernst Blum, Estelle Ngo, Catherine Rolando,Pierre Nimsgern, Sylvie Teixeira-Fouchard,Hansjoerg Lehmann,Pascal Furet,Frederic Berst, Jens Schumann,Rowan Stringer, Patrice Larger, Cindy Schmid, Catriona T. Prendergast, Simone Riek, Patrick Schmutz,Sylvie Lehmann, Jorg Berghausen,Clemens Scheufler,Jean-Michel Rondeau, Christoph Burkhart,Thomas Knoepfel,Nina Gommermann

JOURNAL OF MEDICINAL CHEMISTRYno. 18 (2024): 16692-16711

Cited0Views0WOSBibtex

Optimization of a Class of Dihydrobenzofurane Analogs Toward Orally Efficacious YAP‐TEAD Protein‐Protein Interaction Inhibitors

Holger Sellner,Emilie Chapeau,Pascal Furet,Markus Voegtle,Bahaa Salem,Mickael Le Douget,Vincent Bordas, Jean-Marc Groell, Anne-Laure Le Goff, Christine Rouzet, Thomas Wietlisbach, Thomas Zimmermann, Joseph McKenna,Cara E. E. Brocklehurst,Patrick Chene,Markus Wartmann,Clemens Scheufler,Joerg Kallen,Gareth Williams,Stephanie Harlfinger,Martin Traebert,Berengere M. Dumotier,Tobias Schmelzle,Nicolas Soldermann

CHEMMEDCHEMno. 11 (2023)

Cited3Views0WOSBibtex

The First Class of Small Molecules Potently Disrupting the YAP‐TEAD Interaction by Direct Competition

Pascal Furet,Vincent Bordas,Mickael Le Douget,Bahaa Salem,Yannick Mesrouze,Patricia Imbach-Weese,Holger Sellner,Markus Voegtle,Nicolas Soldermann,Emilie Chapeau,Markus Wartmann,Clemens Scheufler,Cesar Fernandez,Joerg Kallen,Vito Guagnano,Patrick Chene,Tobias Schmelzle

ChemMedChemno. 19 (2022)

Cited16Views0WOSBibtex

Front Cover: The First Class of Small Molecules Potently Disrupting the YAP‐TEAD Interaction by Direct Competition (ChemMedChem 19/2022)

Pascal Furet,Vincent Bordas,Mickaël Le Douget,Bahaâ Salem,Yannick Mesrouze,Patricia Imbach‐Weese,Holger Sellner,Markus Voegtle,Nicolas Soldermann,Emilie A. Chapeau,Markus Wartmann,Clemens Scheufler,César Fernández Fernández,Joerg Kallen,Vito Guagnano,Patrick Chêne,Tobias Schmelzle

ChemMedChemno. 19 (2022)

Cited0Views0Bibtex

Synthesis of the Potent, Selective, and Efficacious Β-Secretase (BACE1) Inhibitor NB-360

Heinrich Rueeger,Rainer Lueoend,Rainer Machauer,Siem J. Veenstra,Philipp Holzer,Konstanze Hurth,Markus Voegtle,Mathias Frederiksen,Jean-Michel Rondeau,Marina Tintelnot-Blomley,Laura H. Jacobson,Matthias Staufenbiel,Grit Laue,Ulf Neumann

Journal of Medicinal Chemistry（2021）

Cited6Views0WOSBibtex

Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious Β-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer's Disease

Rainer Machauer,Rainer Lueoend,Konstanze Hurth,Siem J. Veenstra,Heinrich Rueeger,Markus Voegtle,Marina Tintelnot-Blomley,Jean-Michel Rondeau,Laura H. Jacobson,Grit Laue,Karen Beltz,Ulf Neumann

Journal of Medicinal Chemistry（2021）

Cited6Views0WOSBibtex

Discovery of Amino-1,4-oxazines As Potent BACE-1 Inhibitors

Siem Jakob Veenstra,Heinrich Rueeger,Markus Voegtle,Rainer Lueoend,Philipp Holzer,Konstanze Hurth,Marina Tintelnot-Blomley,Mathias Frederiksen,Jean-Michel Rondeau,Laura Jacobson,Matthias Staufenbiel,Ulf Neumann,Rainer Machauer

Bioorganic & Medicinal Chemistry Letters（2018）

Cited8Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn